| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.18 | 0.6 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |